Brooke Torbett, FNP | |
4233 Highway 411, Madisonville, TN 37354-1571 | |
(423) 442-8084 | |
Not Available |
Full Name | Brooke Torbett |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Family Health |
Location | 4233 Highway 411, Madisonville, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326592809 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SF0001X | Clinical Nurse Specialist - Family Health | 21527 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brooke Torbett, FNP Po Box 1110, Madisonville, TN 37354-1074 Ph: (423) 442-8084 | Brooke Torbett, FNP 4233 Highway 411, Madisonville, TN 37354-1571 Ph: (423) 442-8084 |
News Archive
The spice compound that gives curry dishes their yellow color and pungent flavor is emerging as a prime candidate for a less expensive treatment for Alzheimer's disease (AD), according to an article in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
Adding an antiviral agent to corticosteroids for treatment of Bell's palsy (a condition characterized by partial facial paralysis) is not associated with improved recovery of facial movement function, according to a meta-analysis of previously published studies in the June issue of Archives of Otolaryngology-Head & Neck Surgery.
BioDelivery Sciences International, Inc. today provided a summary of its business overview webcast that was conducted on Thursday, February 25, 2010. Dr. Mark A. Sirgo, President and Chief Executive Officer, and Dr. Andrew L. Finn, Executive Vice President of Product Development, provided an update on the product portfolio, including development plans, anticipated timelines, and key upcoming milestones.
Doctors evaluating patients for blockages in the heart are aided by having a good roadmap of the vascular terrain before they can insert stents to clear the impasse.
› Verified 4 days ago